Savant Capital, LLC Vanda Pharmaceuticals Inc. Transaction History
Savant Capital, LLC
- $12.3 Billion
- Q4 2024
A detailed history of Savant Capital, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 15,094 shares of VNDA stock, worth $66,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,094
Previous 15,298
1.33%
Holding current value
$66,715
Previous $71,000
1.41%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VNDA
# of Institutions
156Shares Held
45.2MCall Options Held
86.1KPut Options Held
40.8K-
Black Rock Inc. New York, NY8.14MShares$36 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$17 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$15.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.4 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $250M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...